{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:09:27Z","timestamp":1648721367517},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol. & Tumor Pharmacother."],"published-print":{"date-parts":[[1992,12]]},"DOI":"10.1007\/bf02987753","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"page":"173-176","source":"Crossref","is-referenced-by-count":0,"title":["Cytosine Arabinoside and Etoposide (CARE) in relapsed and refractory non-hodgkin\u2019s Lymphoma"],"prefix":"10.1007","volume":"9","author":[{"given":"Robert","family":"Mansberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02987753_CR1","first-page":"21","volume":"24","author":"RI Fisher","year":"1987","unstructured":"Fisher RI, Miller TP, Dann BW,et al.: South west oncology group clinical trials for intermediate and high grade non-Hod gkin\u2019s lymphomas.Semin Hematol\n                           24, 21\u201325 (1987).","journal-title":"Semin Hematol"},{"key":"BF02987753_CR2","unstructured":"Fisher R I, Stiff P J: Treatment options for recurrent lymphomas.Semin Oncol (Suppl. 4), 63\u201367 (1990)."},{"key":"BF02987753_CR3","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJM198706113162402","volume":"316","author":"T Takvorain","year":"1987","unstructured":"Takvorain T, Cannelos G P, Ritz J,et al.: Prolonged disease free survival after autologous bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma with a poor prognosis.N Engl J Med\n                           316, 1499\u20131505 (1987).","journal-title":"N Engl J Med"},{"key":"BF02987753_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","volume":"71","author":"W S Velasques","year":"1988","unstructured":"Velasques W S, Cabanillas F, Salvador P,et al.: Effective salvage therapy for lymphoma with DHAP.Blood\n                           71, 117\u2013122 (1988).","journal-title":"Blood"},{"key":"BF02987753_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.1987.5.3.407","volume":"5","author":"F Cabanillas","year":"1987","unstructured":"Cabanillas F, Hagemeister F B, McLaughlin P,et al.: Results of MIME salvage therapy for recurrent or refractory lymphoma.J Clin Oncol\n                           5, 401\u2013412 (1987).","journal-title":"J Clin Oncol"},{"key":"BF02987753_CR6","unstructured":"Velasques W S, Swan F, Redman J,et al.: Combination of etoposide high dose Ara-C and solumedrol with or without platinol in relapsing or recurrent lymphoma.Abstract Proc Asco (1989)."},{"key":"BF02987753_CR7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage J O, Spitzer G,et al.: High dose therapy and autologous transplantation after failure of conventional chemotherapy in adults with intermediate grade of high grade non-Hodgkin\u2019 s lymphoma.N Engl J Med\n                           316, 1493\u20131498 (1987).","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"BF02987753_CR8","first-page":"47","volume":"2","author":"S J Homing","year":"1991","unstructured":"Homing S J, Chao N J, Negrin R T,et al.: The Stanford experience with high dose etoposide cyto-reductive regimens and ABMT in Hodgkin\u2019 s disease and non-Hodgkin\u2019s lymphoma.Annals Oncol\n                           2 (Suppl. 1), 47\u201350 (1991).","journal-title":"Annals Oncol"},{"issue":"Suppl. 1","key":"BF02987753_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/annonc\/2.suppl_1.57","volume":"2","author":"T Philip","year":"1991","unstructured":"Philip T, Chauvin F, Bron D,et al.: PARMA International Protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomised study.Annals Oncol\n                           2 (Suppl. 1), 57\u201364 (1991).","journal-title":"Annals Oncol"},{"key":"BF02987753_CR10","first-page":"47","volume":"25","author":"F Cabanillas","year":"1988","unstructured":"Cabanillas F, Velasques W S, McLaughlin P,et al.: Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin\u2019s disease.Semin Hematol\n                           25, 47\u201350 (1988).","journal-title":"Semin Hematol"},{"key":"BF02987753_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199207093270207","volume":"327","author":"G J Lieschke","year":"1992","unstructured":"Lieschke G J, Burgess A W: Granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor.N Engl J Med\n                           327, 99\u2013107 (1992).","journal-title":"N Engl J Med"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02987753.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02987753\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02987753.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T19:50:56Z","timestamp":1631908256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02987753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["BF02987753"],"URL":"https:\/\/doi.org\/10.1007\/bf02987753","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1992,12]]}}}